One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the highest dose, raising ...
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback